About In vitro ADMET
In vitro ADMET is a company based in Columbia (United States) founded in 2004 was acquired by Discovery Life Sciences in December 2021.. In vitro ADMET offers products and services including In Vitro ADMET Services. In vitro ADMET operates in a competitive market with competitors including Anabios, Kiyatec, Cellply, Lucid Scientific and DiscoverX, among others.
- Headquarter Columbia, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name In Vitro Admet Laboratories, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$100 K (USD), Grant
Sep 09, 2011
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Discovery Life Sciences
(Dec 02, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of In vitro ADMET
In vitro ADMET offers a comprehensive portfolio of products and services, including In Vitro ADMET Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Evaluates drug absorption, metabolism, and toxicity properties
Funding Insights of In vitro ADMET
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $100,000
-
First Round
First Round
(09 Sep 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2011 | Amount | Grant - In vitro ADMET | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in In vitro ADMET
In vitro ADMET has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Discovery Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Provider of diversified services with integrated technology platforms for drug discovery
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by In vitro ADMET
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - In vitro ADMET
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
In Vitro Admet Comparisons
Competitors of In vitro ADMET
In vitro ADMET operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Kiyatec, Cellply, Lucid Scientific and DiscoverX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| domain | founded_year | HQ Location |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| domain | founded_year | HQ Location |
Cell-based assays for drug discovery are developed via CMOS platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about In vitro ADMET
When was In vitro ADMET founded?
In vitro ADMET was founded in 2004 and raised its 1st funding round 7 years after it was founded.
Where is In vitro ADMET located?
In vitro ADMET is headquartered in Columbia, United States.
What does In vitro ADMET do?
In vitro ADMET Laboratories was founded in 2004 and is based in Columbia, United States. Preclinical drug development is supported through in vitro drug metabolism and toxicity testing services. Proprietary IdMOC technology is utilized to model multiple-organ interactions for evaluating drug and metabolite effects in applications like cancer screening. A range of ADMET assays is offered, alongside products such as cryopreserved hepatocytes and 3D Hep-I-Spheres for spheroid cultures.
Who are the top competitors of In vitro ADMET?
In vitro ADMET's top competitors include Metrion Biosciences, CytoTronics and Kiyatec.
What products or services does In vitro ADMET offer?
In vitro ADMET offers In Vitro ADMET Services.
Who are In vitro ADMET's investors?
In vitro ADMET has 2 investors. Key investors include HHS, and Discovery Life Sciences.